| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 373 |
| 1 | SITAGLIPTIN | 137 |
| 2 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 45 |
| 3 | EXENATIDE | 30 |
| 4 | INSULIN GLARGINE | 24 |
| 5 | METFORMIN | 22 |
| 6 | METFORMIN ER 500 MG | 22 |
| 7 | METFORMIN ER 750 MG | 22 |
| 8 | ASPIRIN | 17 |
| 9 | ASPIRIN 325 MG | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANCRELIPASE | 373 | 0.0094 |
| 1 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 2 | 0.0029 |
| 2 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 45 | 0.0021 |
| 3 | SITAGLIPTIN | 137 | 0.0019 |
| 4 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 5 | NATEGLINIDE | 1 | 0.0007 |
| 6 | BUFFERED ASPIRIN | 1 | 0.0007 |
| 7 | AZELASTINE HCL | 1 | 0.0007 |
| 8 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 9 | EXENATIDE | 30 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 41 |
| 1 | Insulin Analog [EPC] | 37 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 4 | Proton Pump Inhibitor [EPC] | 13 |
| 5 | Sulfonylurea [EPC] | 12 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 8 | Vitamin C [EPC] | 8 |
| 9 | Benzodiazepine [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glinide [EPC] | 2 | 0.0002 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Bismuth [EPC] | 1 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | Insulin [EPC] | 5 | 0.0001 |
| 6 | Sulfonylurea [EPC] | 12 | 0.0001 |
| 7 | GLP-1 Receptor Agonist [EPC] | 41 | 0.0001 |
| 8 | Barbiturate [EPC] | 1 | 0.0001 |
| 9 | Insulin Analog [EPC] | 37 | 0.0001 |